Tag results:

prostate cells

Hemin Activation Abrogates Mycoplasma hyorhinis Replication in Chronically Infected Prostate Cancer Cells via Heme Oxygenase-1 Induction

[FEBS Openbio] Researchers described the striking >90% inhibitory effect of hemin, a natural inducer of the cytoprotective enzyme heme oxygenase-1, on M. hyorhinis replication in chronically infected LNCaP prostate cancer cells.

Aromatic Monophenols from Cinnamon Bark Act as Proteasome Inhibitors by Upregulating ER Stress, Suppressing FoxM1 Expression, and Inducing Apoptosis in Prostate Cancer Cells

[Phytotherapy Research] Scientists investigated the anticancer potential of abundant monophenols from cinnamon, namely, cinnamaldehyde, cinnamic acid, and eugenol, by hypothesizing that they possess proteasome inhibitory activities capable of suppressing cancer cell proliferation and inducing apoptosis.

Molecular Analysis of Cell Survival and Death Pathways in the Proteasome Inhibitor Bortezomib-Resistant PC3 Prostate Cancer Cell Line

[Medical Oncology] Researchers verified the resistance levels of parental and resistant PC3 prostate cancer cells to bortezomib using WST-1 test.

Synthesis and In Vitro Preliminary Evaluation of Prostate-Specific Membrane Antigen Targeted Upconversion Nanoparticles as a First Step towards Radio/Fluorescence-Guided Surgery of Prostate Cancer

[Journal of Materials Chemistry B] Researchers successfully developed active targeted upconversion nanoparticles as potential probes for dual near-infrared–near-infrared fluorescence and radioactive-guided surgery of prostate-specific membrane antigen prostate cancers.

The Effect of Cisplatin-Low-Level Laser Therapy on Cell Viability and Death of LNCaP Prostate Cancer Cell Line

[Lasers in Medical Science] Scientists determined the effect of conjugated cisplatin and low-level laser treatment on the viability of LNCaP prostate cancer cell line. LNCaP cells were harvested in DMEM containing 10% FBS and 1% antibiotic.

Dual Anticancer Drug-Loaded Self-Assembled Nanomaterials Delivery System for the Treatment of Prostate Cancer

[Journal of Biomaterials Science] In both PC3pip and LNCAP prostate cancer cells, crizotinib and marizomib nanomaterials demonstrated noticeable cytotoxic effects in a dose-responsive method.

Popular